NEW YORK (GenomeWeb) – Veractye's first quarter revenues increased 70 percent year over year, the molecular cytology firm announced after the close of the market on Thursday.

The South San Francisco, Calif.-based company said that for the three months ended March 31, revenues rose to $7.5 million from $4.4 million in the year-ago quarter as it received 14,373 fine need aspiration samples during the recently completed quarter, compared to 10,757 in the first quarter of 2013.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

In Nature this week: ash dieback disease fungal genome, and more.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.